Business
BMO Beats Quarterly Earnings Again, And Remains A Strong Dividend Idea Among Banks (BMO)
Albert Anthony is the pen name of a business author on Amazon and his newest book is “How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,” now available as a 2026 edition paperback and Kindle ebook in several regions including the US, UK, Canada, and Europe. The author is an analyst & contributor for investing platform Seeking Alpha since 2023, where he has nearly 2,000 followers and has covered hundreds of stocks in multiple sectors including banks/financials, REITs, insurance, pharma, and more. He has also written for platforms like Investing dot com, and has taken part in many business conferences includes Bloomberg Adria’s Investment Outlook 2026 as well as Money Motion 2026. Albert Anthony has Croatian-American roots, having grown up in the US and living in the NYC/New Jersey area as well as the Austin Texas area while working in enterprise IT roles at several prominent companies, including a top 10 financial firm. The author earned a B.A. from Drew University, and also completed certifications from Microsoft, CompTIA, and Corporate Finance Institute where he earned the specialization in risk management. He is founder of a boutique equities research firm, Albert Anthony & Company, which is a trade name both in the US and Croatia. Besides his writing and analyst work, the author has been active on camera as well, as a film/TV extra for casting agencies in Croatia/Europe, and also took part in roundtable panel discussions and appeared in several media stories in that region. You can also check out the author’s video content on the Albert Anthony channel on YouTube where he discusses investing topics, @author.albertanthony Please note: The author does not write about non-publicly traded companies, small cap stocks, crypto, or startup CEOs, so any such mail received and pitches from PR agencies will be deleted. Any official mail to the author should be sent to albertanthony.info@gmail.com. *Author Disclaimer: Albert Anthony and Albert Anthony & Co, is a US-based sole proprietorship registered as a trade name in Austin, Texas, and a sole proprietor registered in Croatia. The author nor his company are registered financial advisors and do not provide personalized financial advisory services to clients and do not manage client assets but provide general markets commentary and research as well as actionable insights based on publicly-available data and their own analysis. The author does not sell or market financial products and services, nor is compensated by any company for rating them. The author does not hold any material position in any stock he rates at the time of writing, unless otherwise disclosed. All investment is assumed to be at risk and readers are expected to do their due diligence beyond the scope of this author’s commentary, agreeing to indemnify the author of any liability for potential investment losses.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Business
Exelixis presents Cabometyx data for neuroendocrine tumors

Exelixis presents Cabometyx data for neuroendocrine tumors
Business
Broadcom, Hewlett Packard Headline Earnings Next Week
Get ahead of the market by subscribing to Seeking Alpha’s Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports, and conference presentations.
The stock market opened higher as traders kept a close watch on any updates related to the U.S.-Iran conflict amid reports of fresh strikes. The U.S. and Iran have reportedly reached a deal; however, President Donald Trump will have to give the final approval. Reports suggested that Iran had launched missiles. The wholesale inventories’ growth slowed less than expected in April, while retail growth came in line.
Major economic data are scheduled for the coming week. S&P Global and ISM Manufacturing PMI data are scheduled for Monday. JOLTS job opening data is due on Tuesday. On Wednesday, data including S&P Global services and composite PMI and ISM non-manufacturing PMI will be released. Initial jobless claims will be out on Thursday, while nonfarm payrolls and the unemployment rate will be released on Friday.
_______________________________________________________________
Earnings spotlight: Monday: Hewlett Packard (HPE) and Credo Technology (CRDO). See the full earnings calendar.
Earnings spotlight: Tuesday: Palo Alto Networks (PANW) and Ulta Beauty (ULTA). See the full earnings calendar.
Earnings spotlight: Wednesday: Broadcom (AVGO), CrowdStrike (CRWD), and Medtronic (MDT). See the full earnings calendar.
Earnings spotlight: Thursday: Ciena Corp. (CIEN), lululemon (LULU), and DocuSign (DOCU). See the full earnings calendar.
Volatility watch: Netflix (NFLX) and Globalstar (GSAT) have seen options volatility increase over the last week. The most overbought stocks per their 14-day relative strength index include Momentus (MNTS), Hyliion (HYLN), and Redwire (RDW). The most oversold stocks per their 14-day Relative Strength Index include Verra Mobility (
Business
First Windows PC powered by Nvidia chips to debut next week, Axios reports

First Windows PC powered by Nvidia chips to debut next week, Axios reports
Business
Colombia accuses Ecuador of “deliberate interference” in presidential election amid tariff spat

Colombia accuses Ecuador of “deliberate interference” in presidential election amid tariff spat
Business
Zscaler: Why I'm Not Buying The Dip
Zscaler: Why I'm Not Buying The Dip
Business
Major Sells and New Buys Under Greg Abel
Warren Buffett’s Berkshire Hathaway executed one of its most significant portfolio overhauls in years during the first quarter of 2026, selling stakes in 16 companies while initiating new positions and boosting others as Greg Abel assumed the CEO role.
The conglomerate’s equity portfolio contracted from about $274 billion to $263 billion, with the number of holdings dropping from around 40 to 29. Berkshire was a net seller, purchasing roughly $16 billion in stocks while selling $24 billion.
Buffett, who stepped down as CEO at the end of 2025 but remains chairman and involved in investment decisions, oversaw the transition period. The Q1 13F filing, released May 15, reflects Abel’s first full quarter leading day-to-day operations.
Key sales and complete exits
Berkshire fully exited several positions, including long-held or more recent stakes. Complete sells included Visa, Mastercard, UnitedHealth Group, Domino’s Pizza, Amazon, Aon, Pool Corp., and others such as Heico, Liberty Media entities, Charter Communications, Lamar Advertising, Allegion, Diageo, Liberty Latin America, and Atlanta Braves Holdings.
Visa and Mastercard exits totaled billions, reflecting a departure from payment processors. The remaining Amazon shares were sold after prior reductions. UnitedHealth and Domino’s also saw full liquidation.
Trimmed positions included Bank of America, Chevron (cut substantially), DaVita, Nucor, and Constellation Brands. Chevron’s reduction was among the largest adjustments despite remaining a top holding.
Notable buys and increases
Berkshire initiated new stakes in Delta Air Lines and Macy’s. The Delta position reached 39.8 million shares, valued at about $2.8 billion, marking a return to airlines after a full exit in 2020 during the pandemic.
The company significantly boosted its Alphabet holdings. Shares of Alphabet Class A (GOOGL) increased by more than 200%, reaching around 54.2 million shares worth roughly $15.6 billion. A new position in Alphabet Class C (GOOG) added about 3.6 million shares valued near $1 billion.
Berkshire also added to existing positions in Chubb and the New York Times, tripling its NYT stake in some reports from prior quarters.
Top holdings remain concentrated
The portfolio stayed highly concentrated, with the top five holdings — Apple, American Express, Coca-Cola, Bank of America, and Chevron — accounting for about 68% of the equity portfolio. Apple alone represented around 22%.
American Express held steady as a core long-term position. Coca-Cola, a decades-long holding, saw no major changes. These “core” names underscore continuity even amid broader adjustments.
Context of the transition
The moves come as Abel reshapes aspects of the portfolio, including unwinding certain positions previously associated with former managers Todd Combs and Ted Weschler. Combs left at the end of 2025.
Berkshire repurchased $234 million of its own shares in the quarter at 144% of book value. Cash levels remained elevated, consistent with recent trends of net stock sales.
Analysts note the portfolio’s concentration and focus on high-quality businesses with durable advantages. Many sales targeted higher-valuation or cyclical names, while additions like Delta reflect opportunistic buying in beaten-down sectors.
Market reaction and implications
The 13F disclosure prompted varied responses. Some investors viewed the Alphabet increase as a nod to technology and AI growth, despite Buffett’s historical caution toward the sector. Delta’s re-entry highlighted potential value in travel recovery.
Exits from payment giants and health care names like UnitedHealth raised questions about sector rotation. Shares of several sold companies saw limited immediate movement, though UnitedHealth traded lower in after-hours following the news.
As of late May 2026, Berkshire’s strategy continues emphasizing long-term value, capital allocation, and insurance float leverage. The company’s Japanese trading house investments, including stakes in companies like Mitsubishi and Marubeni, remain outside the U.S. equity 13F but contribute to overall returns.
Broader investment landscape
Berkshire’s activity occurs against a backdrop of elevated market valuations, interest rate uncertainty, and sector shifts driven by artificial intelligence and energy demand. The portfolio’s reduction in holdings reflects a more focused approach.
Buffett has reiterated in past communications the importance of buying wonderful businesses at fair prices and holding them long-term. While Abel steers day-to-day decisions, continuity with Buffett’s philosophy appears evident in core holdings.
Investors tracking Berkshire often use 13F filings as a delayed signal of strategy, though the conglomerate’s size limits agility compared to smaller funds. Future quarters will reveal whether Q1 changes represent a one-time reset or ongoing evolution.
Looking ahead in 2026
With half the year remaining, additional 13F updates will provide further insight into Berkshire’s direction under Abel. The company’s annual meeting in May offered shareholder perspectives, though specific stock picks remain disclosed quarterly.
Berkshire’s cash pile and operational strength provide flexibility for opportunistic deployments. Analysts will watch for activity in energy, financials, and consumer sectors where the firm has historically excelled.
As always, individual investors should conduct their own due diligence. Berkshire’s moves reflect its unique scale, time horizon, and risk tolerance rather than general recommendations. Stock prices fluctuate, and past performance is no guarantee of future results.
Business
Buy on Dips Amid Strong Growth Despite Mixed Analyst Views
Enlight Renewable Energy Ltd. (NASDAQ: ENLT) presents a nuanced investment case in 2026, with robust project execution and revenue growth supporting a cautious buy recommendation for long-term investors, even as Wall Street maintains a consensus hold rating amid valuation concerns.
The Israeli developer of solar, wind and energy storage projects has seen its shares trade near $102-$103 recently, reflecting strong momentum from U.S. expansion and favorable renewable energy tailwinds. However, analyst price targets average around $60 to $80, implying potential downside from current levels, with some firms highlighting overvaluation risks.
Strong Q1 results and reaffirmed guidance
Enlight reported impressive first-quarter results on May 5, with total revenues and income reaching $200 million, up 54% from the prior year. Adjusted EBITDA climbed to $154 million, and the company delivered a 58% increase in that metric on an adjusted basis excluding one-time gains.
CEO Adi Leviatan highlighted the performance in post-earnings commentary. “2026 is off to a strong start, reflected in consistent and impressive over 50% growth across Enlight’s financial metrics.”
The company reaffirmed its full-year 2026 guidance for total revenues and income between $755 million and $785 million — representing 32% growth — and adjusted EBITDA of $545 million to $565 million, up 27%. It also reiterated a target of more than $2.1 billion in annual revenue run-rate by the end of 2028.
Growth has been driven by new U.S. projects, higher electricity sales, improved wind conditions and tax benefits under the Inflation Reduction Act. The portfolio stands at approximately 5 GW operational or under construction, with significant exposure to solar-plus-storage developments.
U.S. expansion and major contracts
A key highlight came on May 26 when Enlight, through its U.S. subsidiary Clēnera, finalized a 200 MW AC solar power purchase agreement with Google for the Solstice project in Oklahoma. The 15-year fixed-price contract supports data center operations and marks an expansion beyond traditional utility customers.
Leviatan described the deal as a milestone. “By signing this agreement with Google, we are expanding our U.S. customer base beyond utilities to large load commercial customers, including the fast-growing data center sector.”
Analysts point to the U.S. as a primary growth engine, fueled by surging electricity demand from data centers, artificial intelligence infrastructure and manufacturing reshoring. Enlight benefits from long-term power purchase agreements that provide revenue visibility and from federal tax credits.
The company’s diversified portfolio spans Israel, Europe and the United States, with a focus on utility-scale projects that combine generation and storage for grid stability.
Analyst perspectives and valuation
Wall Street opinions remain divided. UBS recently raised its price target to $123 from $105 while maintaining a Buy rating, citing upside from project execution. Other firms like JP Morgan have held Underweight ratings with targets around $68.
Consensus across roughly seven analysts stands at Hold, with an average 12-month price target near $60-$80, suggesting potential moderation from current trading levels. Some models flag the stock as overvalued on traditional metrics such as price-to-earnings, which sits elevated due to growth expectations already priced in.
Supporters argue that discounted cash flow models show undervaluation when factoring in the secured pipeline and visible cash flows. One analysis indicated a potential 45% undervaluation based on long-term projections.
Shares have delivered substantial gains over the past year but remain volatile, typical for growth-oriented renewable developers sensitive to interest rates, policy shifts and commodity prices.
Financial strength and balance sheet
Enlight raised approximately $740 million in capital during the first quarter, bolstering liquidity to around $709 million at the parent level. Operating cash flow rose 58% to $100 million, supporting project development and debt management.
The company maintains a disciplined approach to capital allocation, selling down stakes in certain assets to recycle capital while retaining operational control. Net income for Q1 came in at $38 million, impacted by prior-year one-time gains but showing underlying improvement.
Risks include high debt levels associated with project financing, exposure to geopolitical tensions in Israel, regulatory changes affecting tax incentives, and execution challenges in bringing large projects online. Supply chain issues and interest rate volatility could also pressure margins.
Investment considerations for 2026
For investors evaluating buy or sell decisions, Enlight suits those with a long-term horizon bullish on renewables. The stock may appeal on pullbacks closer to analyst targets, offering entry into a company with visible growth from contracted projects and data center demand.
Income-focused investors should note that Enlight does not currently pay a dividend, prioritizing reinvestment. Growth investors highlight the path to multi-gigawatt scale and potential upside from storage co-location, which commands premium pricing.
Shorter-term traders may exercise caution given mixed ratings and the premium valuation. Broader market sentiment toward renewables, influenced by potential policy shifts in Washington, will play a role.
Recent options activity has shown bullish sentiment with higher call volume, though overall analyst coverage remains balanced between optimism on fundamentals and skepticism on price.
Broader industry context
Enlight operates in a sector benefiting from global decarbonization goals and energy security needs. Rising electricity demand, particularly from tech giants, positions developers with ready sites and execution track records favorably. Equipment costs have moderated, improving project economics.
Challenges persist, including interconnection queues, permitting delays and competition from larger players. Enlight’s focus on the U.S. market, where policy support remains relatively intact, provides a buffer.
As of late May, shares closed around $102-$103. Trading volume and volatility reflect ongoing interest in clean energy names amid fluctuating oil prices and economic data.
Conclusion and forward look
Enlight Renewable Energy enters the remainder of 2026 with momentum from strong quarterly results, major corporate contracts and a clear pipeline. While consensus leans hold due to valuation, bullish analysts see substantial upside for patient investors.
The company’s ability to execute on its 2028 run-rate target will be key. Success in delivering projects on time and within budget could validate higher multiples. Investors should monitor upcoming project milestones, interest rate trends and any updates on U.S. energy policy.
As always, decisions should align with individual risk tolerance, portfolio diversification and consultation with financial advisors. Stock prices fluctuate, and past performance offers no guarantee of future results. This overview draws from publicly available analyst reports and company disclosures as of May 30, 2026.
Business
FDL: Regular Dividends And Relative Value (Reaffirming Buy) (NYSEARCA:FDL)
I have been managing investments for over eight years in capital markets. By qualification I am a CFA Charter holder. I primarily look for discrepancies between the price and value of a security. With a focus on first-principal mindset, I try breaking down ideas into their core- most tangible parts, affecting the theses while deliberately avoiding the non-significant matter into crowding the analysis. If you like my ideas or frameworks, reach out via email/message for more granular and concentrated- portfolio level specific investment researches and ideas. I am at prakhar@shrihittruealphacapital.com.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Readers are advised to fact-check thoroughly before making any investment-related decisions; this reflects the personal views of the author and should not be pursued as formal financial or investment advice in any manner. While every effort has been made to ensure accuracy, errors may exist in the data and financial projections presented. The author is not responsible for any financial gains or losses incurred from investments made based on this content.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Business
Analysts Favor Buy as Earnings Growth and Innovation Drive Stability
Coca-Cola Co. enters the second half of 2026 with resilient performance, prompting Wall Street analysts to maintain a broadly bullish stance on its shares despite macroeconomic pressures and shifting consumer tastes.
The beverage giant, trading around $79 recently, benefits from consistent volume growth, pricing power and a strong dividend history that appeals to income-focused investors. Consensus among roughly 15 analysts points to a “Buy” rating, with average 12-month price targets clustering near $86 to $88 — implying potential upside of about 9% to 12% from late-May levels.
Coca-Cola’s first-quarter results, released in late April, underscored its defensive qualities. Net revenues climbed 12% to $12.5 billion, while organic revenues rose 10%. Comparable earnings per share jumped 18% to 86 cents, beating expectations. Global unit case volume grew 3%.
The company raised its full-year 2026 guidance for comparable EPS growth to 8% to 9% from a prior 7% to 8% range, while holding organic revenue growth at 4% to 5%. Management cited resilient consumer demand in many markets and effective cost management.
New leadership eyes faster adaptation
Henrique Braun, who assumed the CEO role in late March after succeeding James Quincey, has emphasized accelerating innovation. In February remarks ahead of the transition, Braun stressed the need to respond to evolving preferences, including demand for lower-sugar options amid the rise of weight-loss drugs.
“We need to get closer to the consumer and improve our speed to market,” Braun said. “While we have made some progress with our overall success rates over the past several years, our innovation today is not where it needs to be.”
This push aligns with Coca-Cola’s broader strategy to expand beyond traditional carbonated soft drinks into teas, waters, sports drinks, juices and functional beverages. The company has invested in product development to capture growth in emerging categories while protecting its core brands like Coca-Cola, Sprite and Fanta.
Analysts highlight the company’s pricing discipline and geographic diversification as key strengths. Emerging markets in Asia, Latin America and Africa continue to offer long-term volume upside as middle-class populations expand and per-capita consumption remains below developed-market levels.
Financial resilience amid headwinds
Coca-Cola’s balance sheet remains solid. The company generates robust free cash flow — approximately $1.8 billion in the first quarter alone — supporting its dividend, currently yielding around 3%. Its net debt leverage sits comfortably below target levels.
Yet challenges persist. Inflationary pressures, currency volatility in certain regions and cautious consumer spending in developed markets have tempered growth expectations. Some categories face competition from private labels and health-focused alternatives. Geopolitical tensions and supply-chain issues add layers of uncertainty.
Braun acknowledged these dynamics in post-earnings commentary, noting that while many consumers remain resilient, others face pressure from persistent inflation and macroeconomic uncertainty.
The stock has delivered steady gains in 2026 so far, outperforming broader market benchmarks at times, though it remains sensitive to interest-rate movements given its premium valuation. Shares trade at a forward price-to-earnings multiple in the mid-20s, reflecting investor confidence in its moat but leaving limited room for error.
Analyst perspectives and price targets
Major firms maintain positive outlooks. Recent targets range from lows near $80 to highs of $92. Barclays, Citigroup and others have issued upbeat notes citing brand strength and execution.
MarketBeat data shows 15 buy ratings with no sells in recent coverage. The average target of around $86.80 suggests moderate but reliable upside. Longer-term models project continued mid-single-digit revenue growth and EPS expansion into the late 2020s, driven by efficiency gains and portfolio optimization.
Value-oriented investors point to Coca-Cola’s status as a classic defensive play. Its products enjoy near-universal recognition, and the bottling system provides operational leverage. Dividend aristocrat status — with decades of increases — supports its appeal for retirement portfolios.
Growth investors, meanwhile, focus on digital transformation initiatives, sustainability efforts in packaging and water stewardship, and potential in ready-to-drink coffee and energy drinks.
Risks to monitor
Potential downsides include a sharper-than-expected slowdown in consumer spending, adverse rulings in ongoing tax disputes, or failure to innovate quickly enough in health-conscious segments. An escalation in global trade tensions could pressure input costs or currency translation.
Analysts generally view these risks as manageable given Coca-Cola’s scale, pricing power and history of navigating cycles. The company has consistently beaten earnings estimates in recent quarters.
Investment considerations for 2026
For investors weighing buy or sell decisions, Coca-Cola presents a case for accumulation on dips rather than aggressive new purchases at current levels, according to several models. Its stability suits conservative portfolios seeking income and modest capital appreciation.
Those with shorter horizons may prefer waiting for pullbacks closer to the lower end of analyst targets. Long-term holders benefit from the total return potential of dividends reinvested over time.
Coca-Cola’s trajectory in the remainder of 2026 will hinge on execution under Braun’s leadership, macroeconomic conditions and the success of new product launches. With a fortress balance sheet and iconic brands, the company is well-positioned to deliver for shareholders seeking reliability in an uncertain environment.
The stock closed at $79.01 on May 29. Volume and volatility remain typical for a large-cap consumer staple.
As always, individual investors should consider their risk tolerance, time horizon and consult financial advisers. Past performance does not guarantee future results, and stock prices can fluctuate.
Business
Tiny Guyana poised for big Iran oil gains and growth strains

Tiny Guyana poised for big Iran oil gains and growth strains
-
Business6 days agoNYT Strands Answers May 24 2026 Revealed for Puzzle No. 812 Theme Summer Essentials
-
NewsBeat3 days agoIsrael says it has killed new Hamas military leader in Gaza City airstrikes
-
Politics5 days agoBridgerton Season 5: Cast, Release Date And Everything We Know So Far
-
Business4 days agoSelena Gomez Reportedly Upset Over Benny Blanco’s Comments on Her ‘Terrible’ Diet
-
Crypto World4 days agoMicron Crosses $1 Trillion Market Cap as AI Demand Reshapes Memory Sector
-
Tech5 days agoMicrosoft’s quiet Claude Code retreat and the real cost of enterprise AI
-
Business5 days agoBTS Sells Out Four Las Vegas Shows at Allegiant Stadium for ARIRANG World Tour
-
Tech4 days agoChina assigns ID codes to 28,000+ humanoid robots
-
News Videos3 days agoXRP *JUST* SUCCEEDED!!!! CLARITY ACT EXPOSED!!! (SHE EXPOSED IT)
-
Tech1 day agoWaymo dominates autonomous vehicle registrations as Tesla trails behind
-
Tech3 days agoThe Samsung pay deal is the moment Korean unions changed register
-
Tech5 days agoWestone Audio and Etymotic Acquired by Fidelity Collective in Major IEM Market Move
-
Entertainment5 days ago‘Breaking Bad’ Star’s Easy-to-Binge 6-Part Crime Series Spin-Off Is Finally Heading to Free Streaming
-
Tech4 days agoMillions of AI agents imperiled by critical vulnerability in open source package
-
Crypto World6 days agoBrian Armstrong Outlines Crypto Vision for the Future Financial System
-
Crypto World3 days agoSpaceX’s $2 Trillion IPO: Why Tech Giants Nvidia (NVDA), Apple (AAPL), and Microsoft (MSFT) May Face Pressure
-
Crypto World5 days ago
Nvidia (NVDA) CEO Calls on Super Micro to Strengthen Export Controls Amid Smuggling Probe
-
Tech3 days agoNASA taps Blue Origin to deliver lunar rovers for Moon Base initiative
-
NewsBeat5 days agoHottest May day ever as London hits 34.8C in 2C leap from previous records
-
Crypto World22 hours ago
Snowflake (SNOW) Stock Rallies on Strong Q1 Results and AI Product Growth

You must be logged in to post a comment Login